Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

Obesity pipeline

What is next, and who is running it?

The next dated milestone on each program. A hollow marker is a registry primary completion date, not a company readout.

Phase 1 on
ClassNone selected
MechanismNone selected

Phase 1 included.

Clear filters

94 of 94 programs on this timeline

202520262027202820292030Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Today

GLP-1 RA 17

SemaglutideApproved
Registry, Sep 6, 2028
BeinaglutideStage n/r
No dated milestone in 2025 to 2030
Registry, Jun 30, 2027
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
Registry, Jan 5, 2027
Registry, Nov 30, 2026
ExenatidePhase 3
No dated milestone in 2025 to 2030
HDM1002Phase 3
No dated milestone in 2025 to 2030
LiraglutideApproved
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
MazdutidePhase 3
Registry, Dec 31, 2026
Registry, Feb 22, 2028
No dated milestone in 2025 to 2030
TG103Phase 3
No dated milestone in 2025 to 2030
SupaglutidePhase 2/3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

GLP-1/GIP 7

TirzepatideApproved
Registry, Jan 2027
VK2735Phase 3
Registry, Jul 2027
No dated milestone in 2025 to 2030
BGM0504Phase 3
Registry, Feb 28, 2027
CT-388Phase 3
Registry, Nov 12, 2027
HDM1005Phase 3
Registry, Dec 2026
RibupatidePhase 3
Registry, Oct 31, 2027

GLP-1/glucagon 4

Registry, Dec 8, 2026
CotadutidePhase 1
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

GIP/GLP-1/glucagon 2

Registry, Mar 14, 2027
UBT251Phase 3
Registry, Jan 14, 2027

Amylin combo 1

Registry, Mar 2027

Oral small molecule 7

OrforglipronApproved
Registry, Sep 6, 2027
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
Registry, Nov 18, 2026
No dated milestone in 2025 to 2030
TERN-601Phase 2
No dated milestone in 2025 to 2030
VCT220Phase 3
No dated milestone in 2025 to 2030

GLP-1 conjugate 1

Registry, Jan 21, 2027

Amylin 6

Registry, Mar 2028
Registry, Oct 20, 2028
ACCG-2671Phase 1/2
No dated milestone in 2025 to 2030
Registry, Jan 26, 2027
PramlintidePhase 2/3
No dated milestone in 2025 to 2030
ABBV-295Phase 2
No dated milestone in 2025 to 2030

Myostatin/activin 3

No dated milestone in 2025 to 2030
BimagrumabPhase 2
Registry, Dec 31, 2028
GaretosmabPhase 2
No dated milestone in 2025 to 2030

MC4R 1

Registry, Mar 13, 2027

CB1 2

RimonabantPhase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

Lipase inhibitor 1

OrlistatApproved
No dated milestone in 2025 to 2030

Opioid and antidepressant 1

Registry, Dec 31, 2030

Sympathomimetic combo 1

No dated milestone in 2025 to 2030

Monoamine reuptake 2

No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030

SARM 1

EnobosarmPhase 2
No dated milestone in 2025 to 2030

Class not reported 34

Registry, Jun 12, 2028
NimacimabPhase 2
Registry, Nov 20, 2026
ARO-ALK7Phase 1/2
Registry, Feb 2027
SCO-940/CT-G32Preclinical
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
ASC30Phase 3
No dated milestone in 2025 to 2030
Registry, Sep 21, 2027
CT-996Phase 1
No dated milestone in 2025 to 2030
HDM1702Phase 3
No dated milestone in 2025 to 2030
LoxenatidePhase 2/3
No dated milestone in 2025 to 2030
LY4086940Phase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
VRB-101Phase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
CT-868Phase 2
No dated milestone in 2025 to 2030
DA-1726Phase 1
Registry, Nov 9, 2026
HM15211Phase 1
No dated milestone in 2025 to 2030
HS-20094Phase 3
Registry, Nov 13, 2026
MET-233IPhase 1/2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
RAY1225Phase 3
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
CetilistatPhase 1
No dated milestone in 2025 to 2030
CRB-913Phase 1
No dated milestone in 2025 to 2030
GUB014295Phase 1
No dated milestone in 2025 to 2030
LB54640Phase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
VelneperitPhase 2
No dated milestone in 2025 to 2030
No dated milestone in 2025 to 2030
AZD6234Phase 3
Registry, May 4, 2027
No dated milestone in 2025 to 2030

MetAP2 inhibitor 1

BeloranibPhase 3
No dated milestone in 2025 to 2030

Serotonin agonist 1

LorcaserinPhase 1/2
No dated milestone in 2025 to 2030

Small molecule 1

MDR-001Phase 3
No dated milestone in 2025 to 2030